Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Feb 23, 2011


Raymond Woosley, president, CEO and board chairman of the Critical Path Institute, will retire from his position as president on Jan. 31, 2012. The institute's board is currently recruiting for someone to fill this post.

Woosley has said he plans to remain involved in C-Path. After his retirement as president, he will continue serving on the board of directors and leading C-Path’s Arizona Center for Education and Research on Therapeutics.

Woosley launched C-Path in 2005 to provide independent guidance to the US Food and Drug Administration and industry on drug development issues, so that new treatments can enter the market quickly. Under Woosley's leadership, C-Path currently employs more than 50 scientists. The institute has expanded beyond its headquarters in Arizona to operating offices in Rockville, Md., to be closer to the FDA and policy issues in Washington, DC.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.